InBasket AI
Care domain

Pharmacy & Medication Management

Pharmacy and medication-management pathways connect prescriptions, dispensing, refills, stock constraints, substitutions, allergies, interactions, reconciliation, and adherence.

Why it matters

Medication safety is a major patient-safety priority because prescribing, dispensing, refills, substitutions, allergies, interactions, stockouts, and adherence often sit in different workflows. WHO Medication Without Harm guidance emphasizes safer systems, transitions, high-risk medicines, polypharmacy, and patient involvement.

InBasket AI keeps this care-domain pathway connected to one continuous patient record so a small care team can work from a single, trustworthy source of truth — part of expanding access to care for the next billion people.

Designed with reference to recognized global, national, and clinical standards

This care area is designed with reference to a standards ecosystem, including global guidance, national protocols, specialty-society recommendations, interoperability standards, and programme reporting requirements where applicable:

  • WHO Medication Without Harm global patient-safety challenge
  • WHO Model List of Essential Medicines
  • FIP / national pharmacy practice, dispensing, and medication-counselling standards where adopted
  • National formulary, essential medicines list, stock, substitution, and pharmacovigilance requirements
  • National Ministry of Health standard treatment guidelines, essential medicines lists, and local scope-of-practice rules for the implementation setting
  • HL7 FHIR, ICD-10, LOINC, SNOMED CT, and local terminology/coding standards where adopted

Standards sources

These sources substantiate the standards named above. Implementation-specific national protocols are selected from official national or regional authorities during deployment.

  1. World Health Organization guidelines and publications
  2. Official national Ministry of Health protocols for the implementation settingImplementation-specific: selected from the official national or regional authority during deployment.
  3. International Pharmaceutical Federation
  4. HL7 FHIR
  5. WHO ICD classifications
  6. LOINC
  7. SNOMED CT

Evidence sources

See it in your setting.

Start a guided pilot conversation — we’ll map the care setting, deployment model, and first workflows together.

Start a pilot conversation